Automated Variation Measure Indicates Risk of Breast Cancer

This article originally appeared here.
Share this content:
Automated Variation Measure Indicates Risk of Breast Cancer
Automated Variation Measure Indicates Risk of Breast Cancer

(HealthDay News) – A variation measure, estimated from an automated algorithm of the grayscale variation within a mammogram, correlates with the risk of breast cancer as strongly or more so than percent density (PD), according to a study published online July 3 in the Journal of the National Cancer Institute.

John J. Heine, PhD, from the H. Lee Moffitt Cancer Center & Research Institute in Tampa, FL, and colleagues developed an automated, objective measure of grayscale value variation within a mammogram, examined its correlation with breast cancer, and compared its performance with PD. Data were utilized from 3 studies: a case-cohort study involving 217 cases and 2,094 non-case individuals, and two case-control studies involving 928 and 246 cases matched with 1,039 and 516 controls, respectively.

The researchers found that, in all 3 studies, the variation measure correlated significantly with the risk of breast cancer (highest vs lowest quartile: hazard ratio, 7.0; odds ratio, 10.7; odds ratio, 2.6; all Ptrend<0.001). The risk estimates and area under the receiver operating characteristic curves were greater for the variation measure than PD in 2 studies (0.71 and 0.76 vs 0.65 and 0.65); in the third study, the estimates were similar (0.60 and 0.61). In a meta-analysis of the 3 studies, there was a stronger correlation observed between variation and breast cancer than PD and breast cancer (highest vs lowest quartile: relative risk, 3.6 and 2.3, respectively).

"These results suggest that the variation measure is a viable automated mammographic density measure that is consistent across film and digital imaging platforms and may be useful in the clinical setting for risk assessment," the authors write.

Full Text (subscription or payment may be required)

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings


Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs